USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Shengyi Technology Co., Ltd.

USPTO PatentsView assignee record - 67 granted patents across 22 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08L (Compositions OF Macromolecular Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Shengyi ranks #5,180 of 49,997 tracked US assignees by granted-patent volume, with 67 patents across 22 technology areas.

#5,180
of 49,997 US assignees by volume
Top 25%
by Innovation Score (44.7/100)
16.9
avg claims per patent
-34%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5180 · Foreign Corporation #5,180 · 67 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 67 grants
  • UPPER-Q #5,180/49,997
  • PHOTO-FINISH Oncotherapy Science
  • CPC-FOCUS C08L · 22 areas
  • INNOV-PAR 44.7/100
  • CLAIMS-RICH 16.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -34% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Oncotherapy Science, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Shengyi

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Shengyi's Innovation Score is 44.7/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Shengyi's grants concentrate

Shengyi Technology Co., Ltd. is a focused PatentsView assignee: 22 CPC subclasses with 79.1% of grants classified under C08L (Compositions OF Macromolecular Compounds). Peak complete grant year is 2019 (19 grants) versus a trough of 2 in 2015. By volume, Shengyi sits between Oncotherapy Science, Inc. and TCL Research America Inc..

Shengyi's three-year grant acceleration

From 2019–2021 to 2022–2024, Shengyi Technology Co., Ltd. moved from 29 to 15 grants (0.52x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Shengyi's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Shengyi holds 67 patents at rank #5,180, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Shengyi

By rank, the assignees closest to #5,180 in granted patent volume.

Leaders in C08L (Compositions OF Macromolecular Compounds)

Other assignees with the most granted patents in Shengyi's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Shengyi, neither rank-band nor same-CPC leaders (those blocks stay above). In C08L (Compositions OF Macromolecular Compounds), Shengyi ranks #99 of 2,352 assignees by patent count in that subclass.

Shengyi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Shengyi Technology Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 3.0%
2016 2 3.0%
2017 7 10.4%
2018 8 11.9%
2019 19 28.4%
2020 7 10.4%
2021 3 4.5%
2022 4 6.0%
2023 5 7.5%
2024 6 9.0%
2025partial year 4 6.0%

Which technologies does Shengyi Technology Co., Ltd. patent most?

Top 15 of 22 technology areas

Where it ranks

Overall rank by patents

#5,180

of 49,997 tracked assignees

Innovation Score

44.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Shengyi Technology Co., Ltd.'s patent record in context - here's where to go next.

  • Shengyi Technology Co., Ltd.'s lead technology class is C08L (Compositions OF Macromolecular Compounds), 79.1% of its portfolio - see every assignee active in that class. Explore C08L
  • Ranked #5,180 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Shengyi Technology Co., Ltd. against Oncotherapy Science, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 44.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.